Novo Nordisk awards EUR8m to research in children health

Nine grants have been awarded by the Novo Nordisk Foundation for research and to improve children’s health through physical activity. A total of 60 million DKK (ca 8 million Euro) has been granted.

Through its Children, Health and Movement programme, Novo Nordisk Foundation has awarded nine grants to Danish researchers and initiatives focused on the health and physical activity of children.

In Denmark, nine grants have been awarded for projects that aim to increase physical activity among children, ensuring better health, tackling overweight, improving quality of life, and increasing educational opportunities. Denmark’s grants also aim to reduce health inequity among children.

“Insufficient physical activity has become too common in Denmark. Research shows that less than one third of 11- to 15-year-olds are physically active 60 minutes per day as recommended by the Danish Health Authority. We are pleased to support these nine projects, which will broadly create engaging environments that can motivate children and adolescents to experience physical activity as fun, and we very much look forward to following their progress,” explains Hanna Line Jakobsen, Director of Social Programmes, Novo Nordisk Foundation.

Related News

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner